Celularity

Florham Park, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Dec 2025

Post-IPO Debt

Top Investors

Alumni VenturesHuman LongevityS32Heritage GroupUnited Therapeutics

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Celularity's investors?

Celularity's investors include Alumni Ventures, Human Longevity, S32, Heritage Group, United Therapeutics.

Where is Celularity headquartered?

Celularity is headquartered in Florham Park, United States.

What does Celularity do?

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

What stage is Celularity at?

Celularity is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2025.

MLA

"Celularity — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/celularity. Accessed July 1, 2026.

APA

VCBacked. (2025). Celularity — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/celularity

Wikipedia (cite web)

{{cite web |title=Celularity — Funding & Investors |url=https://www.vcbacked.co/company/celularity |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2025.